Related Experiment Video
Updated: Apr 9, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism
Marisol Betensky1,2, Muayad Azzam3, Rachel Sara Bercovitz4
1Division of Hematology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD.
Insights
Guidelines now exist for preventing pediatric venous thromboembolism (VTE) with anticoagulant prophylaxis. Recommendations vary by patient subgroup, with some advised against prophylaxis and others advised for it.
Area of Science:
- Pediatric Hematology
- Thrombosis and Hemostasis
- Clinical Guidelines
Background:
- Venous thromboembolism (VTE) is a major cause of illness in children, especially those hospitalized or with chronic conditions.
- Current anticoagulant prophylaxis strategies for pediatric VTE lack consensus.
Purpose of the Study:
- To provide evidence-based guidelines for anticoagulant prophylaxis in pediatric VTE prevention.
- To support shared decision-making between patients and healthcare professionals.
Main Methods:
- A multidisciplinary panel, including a patient representative, developed the guidelines.
- Systematic evidence reviews were conducted up to April 2025.
- The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to assess evidence certainty and formulate recommendations.
Main Results:
- Twelve recommendations were established for pediatric VTE prophylaxis.
- Conditional recommendations against prophylaxis were made for critically ill children, those with cancer, or trauma.
- Conditional recommendations for prophylaxis were issued for children with antiphospholipid antibody syndrome or on long-term total parenteral nutrition.
Conclusions:
- High-quality data for pediatric VTE prophylaxis are limited.
- Future research should focus on VTE risk assessment models and risk-stratified prophylaxis strategies for pediatric subgroups.
Abstract:
High-quality data on anticoagulant prophylaxis for pediatric VTE prevention are scarce. Key research priorities include the development and validation of subgroups-specific VTE risk assessment models, and evaluation of the safety and efficacy of risk-stratified anticoagulant prophylaxis strategies across different pediatric subgroups.
Background:
Venous thromboembolism (VTE) is a significant cause of morbidity in children, particularly among hospitalized patients and those with chronic medical conditions. There is a lack of consensus on anticoagulant prophylaxis strategies.
Objective:
These evidence-based guidelines from the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) are intended to support patients and health care professionals in decisions about anticoagulant prophylaxis for pediatric VTE prevention.
Methods:
ASH formed a multidisciplinary guideline panel that included 1 patient representative. The University of Kansas Health System supported the guideline development process, including systematic evidence reviews up to April 2025. Clinical questions and outcomes were prioritized according to their importance for clinicians and patients. The panel used the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach to assess certainty in the evidence and make recommendations.
Results:
The panel agreed on 12 recommendations. For pediatric patients with solid cancer, who have experienced trauma, or who are critically ill, the panel issued conditional recommendations suggesting no anticoagulant prophylaxis. For pediatric patients with antiphospholipid antibody syndrome, or those on long-term total parenteral nutrition, the panel issued conditional recommendations suggesting the use of anticoagulant prophylaxis. Other pediatric subgroups addressed included patients with acute lymphoblastic leukemia or lymphoma, surgical and hospitalized patients, and those with a central venous access device.
Conclusions:
High-quality data on anticoagulant prophylaxis for pediatric VTE prevention are scarce. Key research priorities include the development and validation of subgroups-specific VTE risk assessment models, and evaluation of the safety and efficacy of risk-stratified anticoagulant prophylaxis strategies across different pediatric subgroups.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Anticoagulant Drugs: Low-Molecular-Weight Heparins

